tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

APLS Stock Latest News

Short Report: VNET Group short interest at 4-month high
The FlyShort Report: VNET Group short interest at 4-month high
4d ago
ALT
APLS
Closing Bell Movers: Texas Instruments up 8%, F5 up 11% on earnings
PremiumThe Fly
Closing Bell Movers: Texas Instruments up 8%, F5 up 11% on earnings
16d ago
LZ
AHR
Apellis to replace Advanced Energy in S&P 600 at open on 2/2
PremiumThe Fly
Apellis to replace Advanced Energy in S&P 600 at open on 2/2
16d ago
AEIS
APLS
Apellis initiated with an Equal Weight at Barclays
PremiumThe Fly
Apellis initiated with an Equal Weight at Barclays
16d ago
APLS
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
PremiumWeekend Updates
Apellis, Olema, Exicure, Immunovant, LivePerson Insider Shake-Up
20d ago
APLS
IMVT
3 ‘Strong Buy’ Stocks to Buy Now, 1/21/2026, According to Top Analysts
PremiumMarket News3 ‘Strong Buy’ Stocks to Buy Now, 1/21/2026, According to Top Analysts
23d ago
UAL
AEVA
Apellis upgraded to Buy from Neutral at BofA
Premium
The Fly
Apellis upgraded to Buy from Neutral at BofA
23d ago
APLS
Apellis price target lowered to $26 from $29 at Wells Fargo
Premium
The Fly
Apellis price target lowered to $26 from $29 at Wells Fargo
24d ago
APLS
Apellis Pharmaceuticals: European Aspaveli Validation and Growing U.S. C3G/IC-MPGN Traction Underpin Buy Rating
PremiumRatings
Apellis Pharmaceuticals: European Aspaveli Validation and Growing U.S. C3G/IC-MPGN Traction Underpin Buy Rating
28d ago
APLS
Apellis price target raised to $28 from $27 at BofA
PremiumThe Fly
Apellis price target raised to $28 from $27 at BofA
1M ago
APLS
Apellis price target lowered to $35 from $39 at Cantor Fitzgerald
PremiumThe Fly
Apellis price target lowered to $35 from $39 at Cantor Fitzgerald
1M ago
APLS
Apellis Pharmaceuticals: Syfovre and Empaveli Outperformance Plus Pipeline Upside Support Undervalued Buy Rating and $45 Target
PremiumRatings
Apellis Pharmaceuticals: Syfovre and Empaveli Outperformance Plus Pipeline Upside Support Undervalued Buy Rating and $45 Target
1M ago
APLS
Apellis Pharmaceuticals: Durable Growth Outlook and Multiple 2025–2026 Catalysts Support Buy Rating
PremiumRatingsApellis Pharmaceuticals: Durable Growth Outlook and Multiple 2025–2026 Catalysts Support Buy Rating
1M ago
APLS
Apellis Pharmaceuticals: Empaveli Momentum, Syfovre Franchise Durability, and Multi-Indication Expansion Support Reiterated Buy and $45 Target
Premium
Ratings
Apellis Pharmaceuticals: Empaveli Momentum, Syfovre Franchise Durability, and Multi-Indication Expansion Support Reiterated Buy and $45 Target
1M ago
APLS
Apellis falls -17.3%
Premium
The Fly
Apellis falls -17.3%
1M ago
APLS
Apellis reports preliminary FY25 U.S. net product revenues of $689M
PremiumThe Fly
Apellis reports preliminary FY25 U.S. net product revenues of $689M
1M ago
APLS
Apellis announces strategic priorities for 2026
PremiumThe Fly
Apellis announces strategic priorities for 2026
1M ago
APLS
Apellis price target lowered to $48 from $55 at Stifel
PremiumThe Fly
Apellis price target lowered to $48 from $55 at Stifel
2M ago
APLS
Apellis Pharmaceuticals: Buy Rating Affirmed Amidst European Regulatory Milestones and Long-term Growth Potential
PremiumRatings
Apellis Pharmaceuticals: Buy Rating Affirmed Amidst European Regulatory Milestones and Long-term Growth Potential
2M ago
APLS
Roth Capital healthcare analyst holds an analyst/industry conference call
PremiumThe FlyRoth Capital healthcare analyst holds an analyst/industry conference call
2M ago
BDX
JNJ
Buy Rating for Apellis Pharmaceuticals: Strong Empaveli Launch and Long-term Syfovre Potential
Premium
Ratings
Buy Rating for Apellis Pharmaceuticals: Strong Empaveli Launch and Long-term Syfovre Potential
2M ago
APLS
Apellis announces NEJM published ‘positive’ Phase 3 EMPAVELI study data
Premium
The Fly
Apellis announces NEJM published ‘positive’ Phase 3 EMPAVELI study data
2M ago
APLS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >